×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MDRX – veradigm inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MDRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/2
11:00 am
mdrx
Stoltenberg Consulting's Health IT Industry Outlook Report identifies top IT trends impacting 2025 hospital purchasing decisions
Medium
Report
Stoltenberg Consulting's Health IT Industry Outlook Report identifies top IT trends impacting 2025 hospital purchasing decisions
4/2
09:32 am
mdrx
Advantmed, LLC Welcomes Risk Adjustment and Quality Expert Scott Filiault to its Board of Directors [Yahoo! Finance]
Neutral
Report
Advantmed, LLC Welcomes Risk Adjustment and Quality Expert Scott Filiault to its Board of Directors [Yahoo! Finance]
4/2
08:01 am
mdrx
Syracuse Orthopedic Specialists Selects Veradigm to Achieve Exceptional Financial Health and Operational Efficiency
Neutral
Report
Syracuse Orthopedic Specialists Selects Veradigm to Achieve Exceptional Financial Health and Operational Efficiency
4/2
02:09 am
mdrx
Veradigm Inc. (NASDAQ: MDRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Neutral
Report
Veradigm Inc. (NASDAQ: MDRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/27
03:45 pm
mdrx
HiPaaS Hosted its 2nd Hospital AI Conference on March 19th, 2025 at VC Nest in Palo Alto
Neutral
Report
HiPaaS Hosted its 2nd Hospital AI Conference on March 19th, 2025 at VC Nest in Palo Alto
3/25
02:07 am
mdrx
Veradigm Inc. (NASDAQ: MDRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Veradigm Inc. (NASDAQ: MDRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/18
04:47 pm
mdrx
Veradigm Announces Appointment of Two New Independent Directors and Transition of Board Leadership
Medium
Report
Veradigm Announces Appointment of Two New Independent Directors and Transition of Board Leadership
3/18
04:29 pm
mdrx
Veradigm Provides Updates on Fiscal 2023 and 2024 and an Outlook for Fiscal 2025
Medium
Report
Veradigm Provides Updates on Fiscal 2023 and 2024 and an Outlook for Fiscal 2025
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/3
04:55 pm
mdrx
Form 4 Veradigm Inc. For: Apr 01 Filed by: Langan Thomas
Medium
Report
Form 4 Veradigm Inc. For: Apr 01 Filed by: Langan Thomas
4/2
04:57 pm
mdrx
Form 4 Veradigm Inc. For: Apr 01 Filed by: Hammond Lisa
Low
Report
Form 4 Veradigm Inc. For: Apr 01 Filed by: Hammond Lisa
3/26
09:06 pm
mdrx
Form 4 Veradigm Inc. For: Mar 24 Filed by: Sacks Jonathan S
Medium
Report
Form 4 Veradigm Inc. For: Mar 24 Filed by: Sacks Jonathan S
3/26
09:05 pm
mdrx
Form 4 Veradigm Inc. For: Mar 24 Filed by: STONEHILL INSTITUTIONAL PARTNERS LP
Medium
Report
Form 4 Veradigm Inc. For: Mar 24 Filed by: STONEHILL INSTITUTIONAL PARTNERS LP
3/26
08:46 pm
mdrx
Form 4 Veradigm Inc. For: Mar 24 Filed by: ASAR VINIT K
Medium
Report
Form 4 Veradigm Inc. For: Mar 24 Filed by: ASAR VINIT K
3/26
08:45 pm
mdrx
Form 4 Veradigm Inc. For: Mar 24 Filed by: Felt Bruce C. Jr.
Medium
Report
Form 4 Veradigm Inc. For: Mar 24 Filed by: Felt Bruce C. Jr.
3/26
08:45 pm
mdrx
Form 4 Veradigm Inc. For: Mar 24 Filed by: SILVERMAN LOU
Medium
Report
Form 4 Veradigm Inc. For: Mar 24 Filed by: SILVERMAN LOU
3/24
05:58 pm
mdrx
Form 3 Veradigm Inc. For: Mar 19 Filed by: Felt Bruce C. Jr.
Low
Report
Form 3 Veradigm Inc. For: Mar 19 Filed by: Felt Bruce C. Jr.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/12
Allscripts announces full support of HHS' commitment to patients with final interoperability rules
10.7%
4/25 Allscripts Healthcare Solutions Inc (NASDAQ: MDRX) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 7.4%
3/18 Allscripts response to the COVID-19 outbreak 6.0%
3/5 Form 4 ALLSCRIPTS HEALTHCARE For: Mar 05 Filed by: Black Paul 5.8%
4/6 Form DEF 14A ALLSCRIPTS HEALTHCARE For: May 21 5.6%
2/28 Form 4 ALLSCRIPTS HEALTHCARE For: Feb 26 Filed by: Farley Brian 5.3%
1/14 Form 8-K ALLSCRIPTS HEALTHCARE For: Jan 14 5.2%
3/4 Allscripts announces Veradigm AccelRx™ to help reduce patient wait times for specialty medications 4.8%
9/11 Allscripts Healthcare Solutions Inc (NASDAQ: MDRX) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 4.7%
6/19 Point-of-Care Partners Adds Ken Kleinberg as Practice Lead of Innovative Technologies 4.3%
4/25 Allscripts Healthcare Solutions Inc (NASDAQ: MDRX) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 7.4%
3/18 Allscripts response to the COVID-19 outbreak 6.0%
3/5 Form 4 ALLSCRIPTS HEALTHCARE For: Mar 05 Filed by: Black Paul 5.8%
4/6 Form DEF 14A ALLSCRIPTS HEALTHCARE For: May 21 5.6%
2/28 Form 4 ALLSCRIPTS HEALTHCARE For: Feb 26 Filed by: Farley Brian 5.3%
1/14 Form 8-K ALLSCRIPTS HEALTHCARE For: Jan 14 5.2%
3/4 Allscripts announces Veradigm AccelRx™ to help reduce patient wait times for specialty medications 4.8%
9/11 Allscripts Healthcare Solutions Inc (NASDAQ: MDRX) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 4.7%
6/19 Point-of-Care Partners Adds Ken Kleinberg as Practice Lead of Innovative Technologies 4.3%
TOP News Decliners
3/12
Veradigm RxTruePrice Helps Drive Higher Medication Adherence
-12.5%
4/10 Form 4 ALLSCRIPTS HEALTHCARE For: Apr 09 Filed by: Farley Brian -10.7%
3/30 Allscripts helps U.S. healthcare organizations rapidly implement telehealth support for virtual patient visits -8.6%
3/2 Q4/2019 12/31/2019 EPS 0.170 ZacksConsensus 0.140 ActVsEst 0.030 - Beat -8.0%
5/7 Murfreesboro Medical Clinic and SurgiCenter partners with 2bPrecise for precision medicine -5.3%
3/9 Trade Alert: The CEO & Director Of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX), Paul Black, Has Just Spent US$252k Buying Shares [Yahoo! Finance News] -5.1%
12/3 Form 8-K ALLSCRIPTS HEALTHCARE For: Dec 03 -4.8%
4/22 Allscripts Healthcare Solutions Inc (NASDAQ: MDRX) was downgraded by analysts at Jefferies Financial Group Inc from a "buy" rating to a "hold" rating. They now have a $7.00 price target on the stock, down previously from $10.50. -4.6%
8/9 Form 10-Q ALLSCRIPTS HEALTHCARE For: Jun 30 -4.2%
8/27 MaineGeneral Health Expands Allscripts Sunrise™ and FollowMyHealth® Footprint -4.1%
4/10 Form 4 ALLSCRIPTS HEALTHCARE For: Apr 09 Filed by: Farley Brian -10.7%
3/30 Allscripts helps U.S. healthcare organizations rapidly implement telehealth support for virtual patient visits -8.6%
3/2 Q4/2019 12/31/2019 EPS 0.170 ZacksConsensus 0.140 ActVsEst 0.030 - Beat -8.0%
5/7 Murfreesboro Medical Clinic and SurgiCenter partners with 2bPrecise for precision medicine -5.3%
3/9 Trade Alert: The CEO & Director Of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX), Paul Black, Has Just Spent US$252k Buying Shares [Yahoo! Finance News] -5.1%
12/3 Form 8-K ALLSCRIPTS HEALTHCARE For: Dec 03 -4.8%
4/22 Allscripts Healthcare Solutions Inc (NASDAQ: MDRX) was downgraded by analysts at Jefferies Financial Group Inc from a "buy" rating to a "hold" rating. They now have a $7.00 price target on the stock, down previously from $10.50. -4.6%
8/9 Form 10-Q ALLSCRIPTS HEALTHCARE For: Jun 30 -4.2%
8/27 MaineGeneral Health Expands Allscripts Sunrise™ and FollowMyHealth® Footprint -4.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: